Pablo Sarobe

13PUBLICATIONS
55CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursInnate immunityGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 19, 2026
Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Belén Aparicio, Leyre Silva, Marta Ruiz

|Mar 03, 2025
MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma.

Diana Llopiz, Leyre Silva, Marta Ruiz

|Feb 03, 2025
IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy.

Marcos Garcia-Lacarte, Sara C Grijalba, Javier Melchor

|Dec 12, 2024
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response.

Yaiza Senent, Ana Remírez, David Repáraz

|Mar 13, 2024
Dendritic Cells in Cancer Immunology and Immunotherapy.

Laura Hato, Angel Vizcay, Iñaki Eguren

|Feb 12, 2024
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies.

Belen Aparicio, Patrick Theunissen, Sandra Hervas-Stubbs

Pageof 3

Frequent Collaborators

4 joint publications

Juan José Lasarte

3 joint publications

Bruno Sangro

3 joint publications

Sandra Hervás-Stubbs

2 joint publications

Marta Ruiz